Minds Navigating the Diagnosis of Mild Cognitive Impairment
Status unconfirmed · Not applicable
Conditions studied: Cognitive Dysfunction, Mild Cognitive Impairment
In brief
The goal of this clinical trial is to find out if a 9 week group therapy using video from home will help veterans with Mild Cognitive Impairment (MCI). The main questions it aims to answer are: * is the video therapy user-friendly for veterans? * does it improve veterans well-being and quality-of-life? Veterans will be asked to attend nine 1 hour small group video sessions and will complete questionnaires before and after the sessions. Researchers will compare the group of veterans that starts the video sessions right away with a group that waits before starting the video sessions.
Key facts
- Study ID
- NCT05690243
- Run by
- Tuscaloosa Research & Education Advancement Corporation
- People needed
- 160
- Starts
- 2023-10-01
- Expected to finish
- 2025-09-30
- Last updated by the study team
- 2023-11-24
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Veteran
- age 60 or older
- diagnosis of MCI, diagnosed at least a month or longer prior to screening
- diagnosis of at least one cardiovascular risk factor (i.e., hypertension, diabetes mellitus II, hyperlipidemia/hypercholesterolemia, or obesity)
- self-reported cognitive complaint (i.e., "Do you have problems with your memory or thinking abilities?")
- self-reported difficulty adjusting to declines in cognitive functioning (i.e., "Have these problems with memory or thinking impacted you, your life, or others in your life?")
- English speaking, and (h) ability to provide written informed consent
You may not qualify if…
- diagnosis of dementia or a neurodegenerative disorder
- diagnosis of serious mental illness likely to impact cognition (i.e., schizophrenia or bipolar I disorder)
- acutely suicidal or homicidal
- actively psychotic
- active substance use disorder
- limited life expectancy due to a terminal medical condition
- receiving ongoing chemotherapy or radiation treatment at time of screening
- residing in an assisted living or residential care facility
- currently participating in another psychotherapy, health promotion intervention, or cognitive training program, and
- any significant changes to psychotropic medications or medications for memory and cognition in the past month. Participants prescribed psychotropic medications and medications for memory and cognition will be asked to stay on their current dosages for the duration of the study.
Where it is running
- Tuscaloosa VA Medical Center — Tuscaloosa, Alabama, United States (enrolling)
- Salem VA Medical Center — Salem, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.